BIO-RAD CFO Lakkaraju Roop Kalyan exercised Options for 2,906 shares at $0 per share and received 6,326 derivative securities. Investors can see the reported post-transaction positions: 4,151 shares after forfeitures and 3,072 derivative securities after exercises, alongside 4,933 shares reported after the option transactions.
Key Highlights
- Lakkaraju Roop Kalyan received 6,326 derivative securities in an award dated Sep. 4, 2026.
- He forfeited 1,341 shares at $386.11 per share, with 4,151 shares reported afterward.
- The award represented about 100.0% of his resulting derivative securities holding.
BIO-RAD LABORATORIES, INC. (NYSE: BIO) CFO Lakkaraju Roop Kalyan exercised options covering 2,906 shares at $0 per share in transactions dated Sep. 5 and Sep. 6, 2026.
Option Exercise and Related Transactions
The entries were priced at $0 per share. Kalyan also forfeited 1,341 shares in F-coded transactions at $386.11 per share.
Reported Holdings After the Activity
Following the option transactions, Kalyan’s reported share holding was 4,933. The forfeiture transactions were followed by a reported holding of 4,151 shares. The Sep. 4 award represented about 100.0% of his resulting derivative securities holding. After the later option exercises, his reported derivative-securities holding was 3,072. These figures distinguish the reported positions in shares from those in derivative securities.
FAQs
Q: How many BIO-RAD options did Lakkaraju Roop Kalyan exercise?
A: The BIO-RAD CFO exercised options for 2,906 shares at $0 per share. The M-coded transactions were recorded on Sep. 5 and Sep. 6, 2026.
Q: What holdings did the BIO-RAD CFO report after the transactions?
A: Kalyan reported 4,933 shares after the option transactions and 4,151 shares after forfeitures. His reported derivative-securities holding after exercises was 3,072.
Q: What derivative securities did the BIO-RAD CFO receive?
A: Kalyan received 6,326 derivative securities in an award dated Sep. 4, 2026. That award represented about 100.0% of his resulting derivative securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.